Management and Team
Board Of Directors
Veterinary Recombinant Biologics
Mirataz™ (mirtazapine transdermal ointment)
Zimeta™ (dipyrone injection)
epoCat™ (feline recombinant erythropoietin)
Events & Presentations
You are here:
We’d love to hear from you! Send us an email or give us a call, we would be happy to answer your questions.
Please provide an email address where we can contact you
Please subscribe me to your mailing list
Yes, I would occasionally like to receive communications about KindredBio products, news and company updates.
No, thank you.
This iframe contains the logic required to handle Ajax powered Gravity Forms.
1555 Bayshore Hwy, Suite 200
Burlingame, California 94010
Tel (650) 701-7901
Find us on Social Media:
Looking for information about Investor Relations?
KindredBio Announces Submission of European Medicines Agency Filing for Mirataz™
December 21, 2017 - 8:08 am
KindredBio Announces Positive Results from Pivotal Study of Zimeta Oral for Fever in Horses
December 4, 2017 - 8:03 am
Kindred Biosciences Announces Third Quarter 2017 Financial Results
November 7, 2017 - 4:07 pm
Event: Kindred Biosciences to Announce Third Quarter 2017 Financial Results
November 6, 2017 - 10:04 am
Event: Kindred Biosciences to Present at 7th Annual LD Micro Invitational
May 24, 2017 - 10:51 am
Event: Kindred Biosciences to Announce First Quarter 2017 Financial Results
April 24, 2017 - 8:57 am
Announcing our new website:
Scroll to top